On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating breast cancer. However, it’s not as effective as whole breast radiation therapy, so isn’t intended to replace that.
Read more via Fda.gov.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
